DAIC

MARCH 25, 2025

tim.hodson Tue, 03/25/2025 - 16:19 March 25, 2025 Bayer plans to present data from 13 new analyses from across the KERENDIA (finerenone) comprehensive clinical trial program at the American College of Cardiology (ACC) 74 th Annual Scientific Session & Expo 2025 , in Chicago, IL, March 29-31, 2025. Bayer Pharmaceuticals.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Kidney Disease Research 52

DAIC

FEBRUARY 3, 2025

tim.hodson Mon, 02/03/2025 - 12:30 January 29, 2025 Roche announced today that the Tina-quant Lipoprotein (a) Gen.2 More than 90% of the Lp(a) level is influenced by variations in the genes controlling the Lp(a) particle production, 2 in which lifestyle interventions such as diet and exercise have no significant impact.

Cardiovascular Disease 52

Cardiovascular Disease Aortic valve Biomarkers Innovation 52

DAIC

MARCH 25, 2025

tim.hodson Tue, 03/25/2025 - 16:19 March 25, 2025 Bayer plans to present data from 13 new analyses from across t he KERENDIA (finerenone) comprehensive clinical trial program at the American College of Cardiology (ACC) 74 th Annual Scientific Session & Expo 2025 , in Chicago, IL, March 29-31, 2025. Bayer Pharmaceuticals.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Research Academic 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWMP79-AWMP79, February 1, 2025. We assessed safety of moderate intensity exercise in the acute phase and its association with pro-inflammatory cytokines and BDNF expression.Methods:This was a prospective, single center, randomized, pilot of prescribed exercise for patients hospitalized with stroke.

Exercise 40

Exercise Hemorrhage Stroke Strokes 40